Profile	GDS3514 / 204680_s_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	262.668	45
GSM325241	Patient no. 1: treated	379.046	52
GSM325242	Patient no. 9: control	1455.16	82
GSM325243	Patient no. 9: treated	1710.78	84
GSM325244	Patient no. 18: control	640.851	63
GSM325245	Patient no. 18: treated	525.13	59
GSM325246	Patient no. 12: control	298.228	51
GSM325247	Patient no. 12: treated	248.867	49
GSM325248	Patient no. 3: control	212.562	44
GSM325249	Patient no. 3: treated	219.71	45
GSM325250	Patient no. 7: control	186.075	41
GSM325251	Patient no. 7: treated	178.561	42
GSM325252	Patient no. 15: control	380.142	52
GSM325253	Patient no. 15: treated	435.949	55
GSM325254	Patient no. 4: control	309.359	48
GSM325255	Patient no. 4: treated	298.48	46
GSM325256	Patient no. 19: control	349.79	54
GSM325257	Patient no. 19: treated	201.573	44
GSM325258	Patient no. 14: control	262.247	44
GSM325259	Patient no. 14: treated	291.3	43
GSM325260	Patient no. 13: control	288.121	44
GSM325261	Patient no. 13: treated	279.268	42
GSM325262	Patient no. 17: control	291.065	46
GSM325263	Patient no. 17: treated	480.022	57
GSM325264	Patient no. 10: control	370.652	53
GSM325265	Patient no. 10: treated	237.743	41
GSM325266	Patient no. 5: control	121.211	35
GSM325267	Patient no. 5: treated	171.273	44
GSM325268	Patient no. 11: control	357.98	48
GSM325269	Patient no. 11: treated	297.015	50
GSM325270	Patient no. 6: control	847.099	69
GSM325271	Patient no. 6: treated	176.337	39
GSM325272	Patient no. 8: control	365.057	51
GSM325273	Patient no. 8: treated	406.622	55
GSM325274	Patient no. 16: control	304.125	48
GSM325275	Patient no. 16: treated	459.502	59
GSM325276	Patient no. 2: control	469.823	55
GSM325277	Patient no. 2: treated	193.164	46